Long-term blood-thinner study for atrial fibrillation patients
Treatments studied
Part of Heart & circulation clinical trials.
This trial follows people with atrial fibrillation to see how long-term blood-thinning treatment affects outcomes over time. It may help determine which long-term approach best lowers stroke and clot risks for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of atrial fibrillation
- Your stroke-risk score (CHA2DS2-VASc) is greater than 1
- You can understand the study and are willing to sign consent
- You have not had a heart attack (ACS) within the past 12 months
- You have not had a stroke within the past 6 months
- Your kidney, liver, or muscle problems are not severe (for kidneys, creatinine must be 3 mg/dL or less)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This trial looks at ways to help people with atrial fibrillation lower their risk of stroke, premature death, and worsening memory. It may help by identifying which prevention approach works best for a broader community of patients.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
This study tests how well anticoagulant medicines dissolve blood clots in the heart of people with atrial fibrillation. It may help doctors choose the best treatment to prevent strokes.
This study looks at how to better predict both stroke risk and bleeding risk in people with atrial fibrillation. It may help doctors choose safer blood-thinner treatment and follow-up plans.
This study compares two blood-thinning medicines to see which works better for people who have both atrial fibrillation (irregular heartbeat) and heart disease. It aims to reduce the risk of heart attack or stroke while avoiding bleeding problems.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.